Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: E9AUB6
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0016289 | CoA hydrolase activity | 5 | 1 |
GO:0016787 | hydrolase activity | 2 | 1 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 1 |
GO:0016790 | thiolester hydrolase activity | 4 | 1 |
GO:0047617 | acyl-CoA hydrolase activity | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 77 | 81 | PF00656 | 0.349 |
CLV_PCSK_KEX2_1 | 60 | 62 | PF00082 | 0.606 |
CLV_PCSK_PC1ET2_1 | 60 | 62 | PF00082 | 0.681 |
CLV_PCSK_SKI1_1 | 5 | 9 | PF00082 | 0.566 |
DEG_APCC_DBOX_1 | 4 | 12 | PF00400 | 0.550 |
DEG_APCC_DBOX_1 | 87 | 95 | PF00400 | 0.248 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.542 |
DEG_SPOP_SBC_1 | 150 | 154 | PF00917 | 0.490 |
DOC_CYCLIN_yCln2_LP_2 | 53 | 59 | PF00134 | 0.638 |
DOC_MAPK_gen_1 | 120 | 130 | PF00069 | 0.408 |
DOC_USP7_MATH_1 | 74 | 78 | PF00917 | 0.495 |
DOC_WW_Pin1_4 | 151 | 156 | PF00397 | 0.553 |
DOC_WW_Pin1_4 | 38 | 43 | PF00397 | 0.614 |
LIG_14-3-3_CanoR_1 | 28 | 35 | PF00244 | 0.728 |
LIG_BRCT_BRCA1_1 | 106 | 110 | PF00533 | 0.331 |
LIG_FHA_1 | 117 | 123 | PF00498 | 0.309 |
LIG_FHA_1 | 146 | 152 | PF00498 | 0.540 |
LIG_FHA_1 | 2 | 8 | PF00498 | 0.663 |
LIG_IRF3_LxIS_1 | 99 | 104 | PF10401 | 0.292 |
LIG_LIR_Gen_1 | 127 | 135 | PF02991 | 0.296 |
LIG_LIR_Gen_1 | 80 | 89 | PF02991 | 0.319 |
LIG_LIR_Nem_3 | 127 | 133 | PF02991 | 0.296 |
LIG_LIR_Nem_3 | 80 | 85 | PF02991 | 0.319 |
LIG_SH2_STAP1 | 30 | 34 | PF00017 | 0.655 |
MOD_CDC14_SPxK_1 | 41 | 44 | PF00782 | 0.663 |
MOD_CDK_SPK_2 | 151 | 156 | PF00069 | 0.553 |
MOD_CDK_SPxK_1 | 38 | 44 | PF00069 | 0.664 |
MOD_CK1_1 | 104 | 110 | PF00069 | 0.363 |
MOD_CK1_1 | 63 | 69 | PF00069 | 0.568 |
MOD_GlcNHglycan | 106 | 109 | PF01048 | 0.400 |
MOD_GlcNHglycan | 136 | 142 | PF01048 | 0.324 |
MOD_GlcNHglycan | 30 | 33 | PF01048 | 0.635 |
MOD_GSK3_1 | 124 | 131 | PF00069 | 0.433 |
MOD_GSK3_1 | 145 | 152 | PF00069 | 0.559 |
MOD_GSK3_1 | 34 | 41 | PF00069 | 0.653 |
MOD_GSK3_1 | 97 | 104 | PF00069 | 0.301 |
MOD_LATS_1 | 26 | 32 | PF00433 | 0.543 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.596 |
MOD_NEK2_1 | 101 | 106 | PF00069 | 0.314 |
MOD_NEK2_1 | 34 | 39 | PF00069 | 0.745 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.562 |
MOD_PKA_1 | 60 | 66 | PF00069 | 0.669 |
MOD_PKA_2 | 145 | 151 | PF00069 | 0.566 |
MOD_PKA_2 | 60 | 66 | PF00069 | 0.679 |
MOD_Plk_1 | 101 | 107 | PF00069 | 0.303 |
MOD_Plk_1 | 131 | 137 | PF00069 | 0.304 |
MOD_Plk_2-3 | 97 | 103 | PF00069 | 0.335 |
MOD_Plk_4 | 124 | 130 | PF00069 | 0.351 |
MOD_Plk_4 | 34 | 40 | PF00069 | 0.722 |
MOD_Plk_4 | 49 | 55 | PF00069 | 0.619 |
MOD_ProDKin_1 | 151 | 157 | PF00069 | 0.555 |
MOD_ProDKin_1 | 38 | 44 | PF00069 | 0.616 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PFU0 | Leptomonas seymouri | 73% | 100% |
A0A0S4JPU2 | Bodo saltans | 33% | 100% |
A0A1X0NLI9 | Trypanosomatidae | 46% | 100% |
A0A3S7XCF9 | Leishmania donovani | 90% | 100% |
A0A422NVU3 | Trypanosoma rangeli | 49% | 100% |
A4HQK3 | Leishmania braziliensis | 79% | 100% |
A4ICC1 | Leishmania infantum | 91% | 100% |
D0A3Q4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 100% |
Q4Q074 | Leishmania major | 91% | 100% |